Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_32f57a53515b98afbb284cb39a2f17f7 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-05 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B59-00 |
filingDate |
2013-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2021-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff033a5a9da8bddbe569d576105d2974 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64273a90f1093784c5e167be40808a9e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b27687302d29d329d516f372c071f14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_634f8d1e50258d2adef7e666d755b4f6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_102443988650bb7a8a3455fb08a2ec47 |
publicationDate |
2021-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
ES-2867048-T3 |
titleOfInvention |
Ruxolitinib deuterated derivatives |
abstract |
A compound of formula I: ** (See formula) ** or a pharmaceutically acceptable salt thereof, in which: Y6, Y7 and Y8 are each hydrogen and the compound (comp.) Is set forth in the table below : ** (See formula) ** in which each atom not indicated as "D" (deuterium) is present in its natural isotopic abundance, and in which a position specifically indicated as "D" has at least 90% of incorporation of deuterium. |
priorityDate |
2012-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |